RONCATO, Rossana
RONCATO, Rossana
DMED - DIPARTIMENTO DI MEDICINA
A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study
2023-01-01 Swen, Jesse J; van der Wouden, Cathelijne H; Manson, Lisanne En; Abdullah-Koolmees, Heshu; Blagec, Kathrin; Blagus, Tanja; Böhringer, Stefan; Cambon-Thomsen, Anne; Cecchin, Erika; Cheung, Ka-Chun; Deneer, Vera Hm; Dupui, Mathilde; Ingelman-Sundberg, Magnus; Jonsson, Siv; Joefield-Roka, Candace; Just, Katja S; Karlsson, Mats O; Konta, Lidija; Koopmann, Rudolf; Kriek, Marjolein; Lehr, Thorsten; Mitropoulou, Christina; Rial-Sebbag, Emmanuelle; Rollinson, Victoria; Roncato, Rossana; Samwald, Matthias; Schaeffeler, Elke; Skokou, Maria; Schwab, Matthias; Steinberger, Daniela; Stingl, Julia C; Tremmel, Roman; Turner, Richard M; van Rhenen, Mandy H; Dávila Fajardo, Cristina L; Dolžan, Vita; Patrinos, George P; Pirmohamed, Munir; Sunder-Plassmann, Gere; Toffoli, Giuseppe; Guchelaar, Henk-Jan
A Systematic Review and a Meta-Analysis Comparing Prophylactic and Therapeutic Low Molecular Weight Heparins for Mortality Reduction in 32,688 COVID-19 Patients
2021-01-01 Giossi, Riccardo; Menichelli, Danilo; Pani, Arianna; Tratta, Elena; Romandini, Alessandra; Roncato, Rossana; Nani, Alessandro; Schenardi, Paolo; Diani, Erika; Fittipaldo, Veronica Andrea; Farcomeni, Alessio; Scaglione, Francesco; Pastori, Daniele
A TGF-β associated genetic score to define prognosis and platinum sensitivity in advanced epithelial ovarian cancer
2019-01-01 Gagno, S.; Poletto, E.; Bartoletti, M.; Quartuccio, L.; Romualdi, C.; Garziera, M.; Scalone, S.; Sorio, R.; Dreussi, E.; Zanusso, C.; De Mattia, E.; Roncato, R.; Cecchin, E.; Giorda, G.; De Vita, S.; Dal Bo, M.; Puglisi, F.; Toffoli, G.
An Integrated Pharmacological Counselling Approach to Guide Decision-Making in the Treatment with CDK4/6 Inhibitors for Metastatic Breast Cancer
2022-01-01 Roncato, R.; Gerratana, L.; Palmero, L.; Gagno, S.; Poetto, A. S.; Peruzzi, E.; Zanchetta, M.; Posocco, B.; De Mattia, E.; Canil, G.; Alberti, M.; Orleni, M.; Toffoli, G.; Puglisi, F.; Cecchin, E.
Association of ADME gene polymorphisms on toxicity to CDK4/6 inhibitors in patients with HR+ HER2- metastatic breast cancer
2023-01-01 Peruzzi, Elena; Gerratana, Lorenzo; Montico, Marcella; Posocco, Bianca; Corsetti, Serena; Bartoletti, Michele; Gagno, Sara; Orleni, Marco; De Mattia, Elena; Baraldo, Massimo; Cecchin, Erika; Puglisi, Fabio; Toffoli, Giuseppe; Roncato, Rossana
Association of STAT-3 rs1053004 and VDR rs11574077 With FOLFIRI-Related Gastrointestinal Toxicity in Metastatic Colorectal Cancer Patients
2018-01-01 De Mattia, Elena; Cecchin, Erika; Montico, Marcella; Labriet, Adrien; Guillemette, Chantal; Dreussi, Eva; Roncato, Rossana; Bignucolo, Alessia; Buonadonna, Angela; D'Andrea, Mario; Coppola, Luigi; Lonardi, Sara; Lévesque, Eric; Jonker, Derek; Couture, Félix; Toffoli, Giuseppe
Body mass index impacts adverse events and drug plasma concentration: should dose intensity be included in the palbociclib equation?
2024-01-01 Roncato, Rossana; Puglisi, Fabio; Gerratana, Lorenzo
Cancer Pharmacogenetics: perspective on newly discovered and implemented predictive biomarkers
2021-01-01 Roncato, R.; Cecchin, E.; Dalle Fratte, C.; Decorti, G.; Del Re, M.; Franca, R.; Nobili, S.; Ravegnini, G.; Stocco, G.; Mini, E.; Toffoli, G.; Cancer Pharmacology Working Group, W. G.
Candidate germline polymorphisms of genes belonging to the pathways of four drugs used in osteosarcoma standard chemotherapy associated with risk, survival and toxicity in non-metastatic high-grade osteosarcoma
2016-01-01 Hattinger, Claudia M; Biason, Paola; Iacoboni, Erika; Gagno, Sara; Fanelli, Marilù; Tavanti, Elisa; Vella, Serena; Ferrari, Stefano; Roli, Andrea; Roncato, Rossana; Giodini, Luciana; Scotlandi, Katia; Picci, Piero; Toffoli, Giuseppe; Serra, Massimo
CDK4/6 Inhibitors in Breast Cancer Treatment: Potential Interactions with Drug, Gene, and Pathophysiological Conditions
2020-01-01 Roncato, Rossana; Angelini, Jacopo; Pani, Arianna; Cecchin, Erika; Sartore-Bianchi, Andrea; Siena, Salvatore; De Mattia, Elena; Scaglione, Francesco; Toffoli, Giuseppe
Cisplatin resistance can be curtailed by blunting Bnip3-mediated mitochondrial autophagy
2022-01-01 Vianello, Caterina; Cocetta, Veronica; Catanzaro, Daniela; Dorn, Gerald W; De Milito, Angelo; Rizzolio, Flavio; Canzonieri, Vincenzo; Cecchin, Erika; Roncato, Rossana; Toffoli, Giuseppe; Quagliariello, Vincenzo; Di Mauro, Annabella; Losito, Simona; Maurea, Nicola; Cono, Scaffa; Sales, Gabriele; Scorrano, Luca; Giacomello, Marta; Montopoli, Monica
Clinical impact of body mass index on palbociclib treatment outcomes and effect on exposure
2023-01-01 Roncato, R.; Peruzzi, E.; Gerratana, L.; Posocco, B.; Nuzzo, S.; Montico, M.; Orleni, M.; Corsetti, S.; Bartoletti, M.; Gagno, S.; Canil, G.; De Mattia, E.; Angelini, J.; Baraldo, M.; Puglisi, F.; Cecchin, E.; Toffoli, G.
Clinical validity of a DPYD-based pharmacogenetic test to predict severe toxicity to fluoropyrimidines
2015-01-01 Toffoli, Giuseppe; Giodini, Luciana; Buonadonna, Angela; Berretta, Massimiliano; De Paoli, Antonino; Scalone, Simona; Miolo, Gianmaria; Mini, Enrico; Nobili, Stefania; Lonardi, Sara; Pella, Nicoletta; Lo Re, Giovanni; Montico, Marcella; Roncato, Rossana; Dreussi, Eva; Gagno, Sara; Cecchin, Erika
Clonal Evolution of TP53 c.375+1G>A Mutation in Pre- and Post- Neo-Adjuvant Chemotherapy (NACT) Tumor Samples in High-Grade Serous Ovarian Cancer (HGSOC)
2019-01-01 Garziera, Marica; Cecchin, Erika; Giorda, Giorgio; Sorio, Roberto; Scalone, Simona; Mattia, Elena De; Roncato, Rossana; Gagno, Sara; Poletto, Elena; Romanato, Loredana; Ecca, Fabrizio; Canzonieri, Vincenzo; Toffoli, Giuseppe
Correction: Cisplatin resistance can be curtailed by blunting Bnip3-mediated mitochondrial autophagy (Cell Death & Disease, (2022), 13, 4, (398), 10.1038/s41419-022-04741-9)
2022-01-01 Vianello, C.; Cocetta, V.; Catanzaro, D.; Dorn, G. W.; De Milito, A.; Rizzolio, F.; Canzonieri, V.; Cecchin, E.; Roncato, R.; Toffoli, G.; Quagliariello, V.; Di Mauro, A.; Losito, S.; Maurea, N.; Cono, S.; Sales, G.; Scorrano, L.; Giacomello, M.; Montopoli, M.
Cost Evaluation of Irinotecan-Related Toxicities Associated With the UGT1A1*28 Patient Genotype
2017-01-01 Roncato, R; Cecchin, E; Montico, M; De Mattia, E; Giodini, L; Buonadonna, A; Solfrini, V; Innocenti, F; Toffoli, G
Cost-utility analysis and cross-country comparison of pharmacogenomics-guided treatment in colorectal cancer patients participating in the U-PGx PREPARE study
2023-01-01 Fragoulakis, Vasileios; Roncato, Rossana; Bignucolo, Alessia; Patrinos, George P.; Toffoli, Giuseppe; Cecchin, Erika; Mitropoulou, Christina
CYP2D6 and CYP2C8 pharmacogenetics and pharmacological interactions to predict imatinib plasmatic exposure in GIST patients
2023-01-01 Dalle Fratte, C.; Gagno, S.; Roncato, R.; Polesel, J.; Zanchetta, M.; Buzzo, M.; Posocco, B.; De Mattia, E.; Borsatti, R.; Puglisi, F.; Foltran, L.; Guardascione, M.; Buonadonna, A.; Cecchin, E.; Toffoli, G.
DPYD gene activity score (GAS) predicts dose-limiting toxicity in fluoropyrimidine-treated colorectal cancer patients
2018-01-01 DALLE FRATTE, Chiara; Polesel, Jerry; Roncato, Rossana; De Mattia, Elena; Ecca, Fabrizio; Bignucolo, Alessia; Garziera, Marica; Dreussi, Eva; Palazzari, Elisa; Buonadonna, Angela; Guardascione, Michela; Berretta, Massimiliano; Foltran, Luisa; Sartor, Franca; D'Andrea, Mario; Favaretto, Adolfo; Mini, Enrico; Nobili, Stefania; De Paoli, Antonino; Toffoli, Giuseppe; Cecchin, Erika
Estimating the Effectiveness of DPYD Genotyping in Italian Individuals Suffering from Cancer Based on the Cost of Chemotherapy-Induced Toxicity
2019-01-01 Fragoulakis, V.; Roncato, R.; Fratte, C. D.; Ecca, F.; Bartsakoulia, M.; Innocenti, F.; Toffoli, G.; Cecchin, E.; Patrinos, G. P.; Mitropoulou, C.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study | 1-gen-2023 | Swen, Jesse J; van der Wouden, Cathelijne H; Manson, Lisanne En; Abdullah-Koolmees, Heshu; Blagec, Kathrin; Blagus, Tanja; Böhringer, Stefan; Cambon-Thomsen, Anne; Cecchin, Erika; Cheung, Ka-Chun; Deneer, Vera Hm; Dupui, Mathilde; Ingelman-Sundberg, Magnus; Jonsson, Siv; Joefield-Roka, Candace; Just, Katja S; Karlsson, Mats O; Konta, Lidija; Koopmann, Rudolf; Kriek, Marjolein; Lehr, Thorsten; Mitropoulou, Christina; Rial-Sebbag, Emmanuelle; Rollinson, Victoria; Roncato, Rossana; Samwald, Matthias; Schaeffeler, Elke; Skokou, Maria; Schwab, Matthias; Steinberger, Daniela; Stingl, Julia C; Tremmel, Roman; Turner, Richard M; van Rhenen, Mandy H; Dávila Fajardo, Cristina L; Dolžan, Vita; Patrinos, George P; Pirmohamed, Munir; Sunder-Plassmann, Gere; Toffoli, Giuseppe; Guchelaar, Henk-Jan | |
| A Systematic Review and a Meta-Analysis Comparing Prophylactic and Therapeutic Low Molecular Weight Heparins for Mortality Reduction in 32,688 COVID-19 Patients | 1-gen-2021 | Giossi, Riccardo; Menichelli, Danilo; Pani, Arianna; Tratta, Elena; Romandini, Alessandra; Roncato, Rossana; Nani, Alessandro; Schenardi, Paolo; Diani, Erika; Fittipaldo, Veronica Andrea; Farcomeni, Alessio; Scaglione, Francesco; Pastori, Daniele | |
| A TGF-β associated genetic score to define prognosis and platinum sensitivity in advanced epithelial ovarian cancer | 1-gen-2019 | Gagno, S.; Poletto, E.; Bartoletti, M.; Quartuccio, L.; Romualdi, C.; Garziera, M.; Scalone, S.; Sorio, R.; Dreussi, E.; Zanusso, C.; De Mattia, E.; Roncato, R.; Cecchin, E.; Giorda, G.; De Vita, S.; Dal Bo, M.; Puglisi, F.; Toffoli, G. | |
| An Integrated Pharmacological Counselling Approach to Guide Decision-Making in the Treatment with CDK4/6 Inhibitors for Metastatic Breast Cancer | 1-gen-2022 | Roncato, R.; Gerratana, L.; Palmero, L.; Gagno, S.; Poetto, A. S.; Peruzzi, E.; Zanchetta, M.; Posocco, B.; De Mattia, E.; Canil, G.; Alberti, M.; Orleni, M.; Toffoli, G.; Puglisi, F.; Cecchin, E. | |
| Association of ADME gene polymorphisms on toxicity to CDK4/6 inhibitors in patients with HR+ HER2- metastatic breast cancer | 1-gen-2023 | Peruzzi, Elena; Gerratana, Lorenzo; Montico, Marcella; Posocco, Bianca; Corsetti, Serena; Bartoletti, Michele; Gagno, Sara; Orleni, Marco; De Mattia, Elena; Baraldo, Massimo; Cecchin, Erika; Puglisi, Fabio; Toffoli, Giuseppe; Roncato, Rossana | |
| Association of STAT-3 rs1053004 and VDR rs11574077 With FOLFIRI-Related Gastrointestinal Toxicity in Metastatic Colorectal Cancer Patients | 1-gen-2018 | De Mattia, Elena; Cecchin, Erika; Montico, Marcella; Labriet, Adrien; Guillemette, Chantal; Dreussi, Eva; Roncato, Rossana; Bignucolo, Alessia; Buonadonna, Angela; D'Andrea, Mario; Coppola, Luigi; Lonardi, Sara; Lévesque, Eric; Jonker, Derek; Couture, Félix; Toffoli, Giuseppe | |
| Body mass index impacts adverse events and drug plasma concentration: should dose intensity be included in the palbociclib equation? | 1-gen-2024 | Roncato, Rossana; Puglisi, Fabio; Gerratana, Lorenzo | |
| Cancer Pharmacogenetics: perspective on newly discovered and implemented predictive biomarkers | 1-gen-2021 | Roncato, R.; Cecchin, E.; Dalle Fratte, C.; Decorti, G.; Del Re, M.; Franca, R.; Nobili, S.; Ravegnini, G.; Stocco, G.; Mini, E.; Toffoli, G.; Cancer Pharmacology Working Group, W. G. | |
| Candidate germline polymorphisms of genes belonging to the pathways of four drugs used in osteosarcoma standard chemotherapy associated with risk, survival and toxicity in non-metastatic high-grade osteosarcoma | 1-gen-2016 | Hattinger, Claudia M; Biason, Paola; Iacoboni, Erika; Gagno, Sara; Fanelli, Marilù; Tavanti, Elisa; Vella, Serena; Ferrari, Stefano; Roli, Andrea; Roncato, Rossana; Giodini, Luciana; Scotlandi, Katia; Picci, Piero; Toffoli, Giuseppe; Serra, Massimo | |
| CDK4/6 Inhibitors in Breast Cancer Treatment: Potential Interactions with Drug, Gene, and Pathophysiological Conditions | 1-gen-2020 | Roncato, Rossana; Angelini, Jacopo; Pani, Arianna; Cecchin, Erika; Sartore-Bianchi, Andrea; Siena, Salvatore; De Mattia, Elena; Scaglione, Francesco; Toffoli, Giuseppe | |
| Cisplatin resistance can be curtailed by blunting Bnip3-mediated mitochondrial autophagy | 1-gen-2022 | Vianello, Caterina; Cocetta, Veronica; Catanzaro, Daniela; Dorn, Gerald W; De Milito, Angelo; Rizzolio, Flavio; Canzonieri, Vincenzo; Cecchin, Erika; Roncato, Rossana; Toffoli, Giuseppe; Quagliariello, Vincenzo; Di Mauro, Annabella; Losito, Simona; Maurea, Nicola; Cono, Scaffa; Sales, Gabriele; Scorrano, Luca; Giacomello, Marta; Montopoli, Monica | |
| Clinical impact of body mass index on palbociclib treatment outcomes and effect on exposure | 1-gen-2023 | Roncato, R.; Peruzzi, E.; Gerratana, L.; Posocco, B.; Nuzzo, S.; Montico, M.; Orleni, M.; Corsetti, S.; Bartoletti, M.; Gagno, S.; Canil, G.; De Mattia, E.; Angelini, J.; Baraldo, M.; Puglisi, F.; Cecchin, E.; Toffoli, G. | |
| Clinical validity of a DPYD-based pharmacogenetic test to predict severe toxicity to fluoropyrimidines | 1-gen-2015 | Toffoli, Giuseppe; Giodini, Luciana; Buonadonna, Angela; Berretta, Massimiliano; De Paoli, Antonino; Scalone, Simona; Miolo, Gianmaria; Mini, Enrico; Nobili, Stefania; Lonardi, Sara; Pella, Nicoletta; Lo Re, Giovanni; Montico, Marcella; Roncato, Rossana; Dreussi, Eva; Gagno, Sara; Cecchin, Erika | |
| Clonal Evolution of TP53 c.375+1G>A Mutation in Pre- and Post- Neo-Adjuvant Chemotherapy (NACT) Tumor Samples in High-Grade Serous Ovarian Cancer (HGSOC) | 1-gen-2019 | Garziera, Marica; Cecchin, Erika; Giorda, Giorgio; Sorio, Roberto; Scalone, Simona; Mattia, Elena De; Roncato, Rossana; Gagno, Sara; Poletto, Elena; Romanato, Loredana; Ecca, Fabrizio; Canzonieri, Vincenzo; Toffoli, Giuseppe | |
| Correction: Cisplatin resistance can be curtailed by blunting Bnip3-mediated mitochondrial autophagy (Cell Death & Disease, (2022), 13, 4, (398), 10.1038/s41419-022-04741-9) | 1-gen-2022 | Vianello, C.; Cocetta, V.; Catanzaro, D.; Dorn, G. W.; De Milito, A.; Rizzolio, F.; Canzonieri, V.; Cecchin, E.; Roncato, R.; Toffoli, G.; Quagliariello, V.; Di Mauro, A.; Losito, S.; Maurea, N.; Cono, S.; Sales, G.; Scorrano, L.; Giacomello, M.; Montopoli, M. | |
| Cost Evaluation of Irinotecan-Related Toxicities Associated With the UGT1A1*28 Patient Genotype | 1-gen-2017 | Roncato, R; Cecchin, E; Montico, M; De Mattia, E; Giodini, L; Buonadonna, A; Solfrini, V; Innocenti, F; Toffoli, G | |
| Cost-utility analysis and cross-country comparison of pharmacogenomics-guided treatment in colorectal cancer patients participating in the U-PGx PREPARE study | 1-gen-2023 | Fragoulakis, Vasileios; Roncato, Rossana; Bignucolo, Alessia; Patrinos, George P.; Toffoli, Giuseppe; Cecchin, Erika; Mitropoulou, Christina | |
| CYP2D6 and CYP2C8 pharmacogenetics and pharmacological interactions to predict imatinib plasmatic exposure in GIST patients | 1-gen-2023 | Dalle Fratte, C.; Gagno, S.; Roncato, R.; Polesel, J.; Zanchetta, M.; Buzzo, M.; Posocco, B.; De Mattia, E.; Borsatti, R.; Puglisi, F.; Foltran, L.; Guardascione, M.; Buonadonna, A.; Cecchin, E.; Toffoli, G. | |
| DPYD gene activity score (GAS) predicts dose-limiting toxicity in fluoropyrimidine-treated colorectal cancer patients | 1-gen-2018 | DALLE FRATTE, Chiara; Polesel, Jerry; Roncato, Rossana; De Mattia, Elena; Ecca, Fabrizio; Bignucolo, Alessia; Garziera, Marica; Dreussi, Eva; Palazzari, Elisa; Buonadonna, Angela; Guardascione, Michela; Berretta, Massimiliano; Foltran, Luisa; Sartor, Franca; D'Andrea, Mario; Favaretto, Adolfo; Mini, Enrico; Nobili, Stefania; De Paoli, Antonino; Toffoli, Giuseppe; Cecchin, Erika | |
| Estimating the Effectiveness of DPYD Genotyping in Italian Individuals Suffering from Cancer Based on the Cost of Chemotherapy-Induced Toxicity | 1-gen-2019 | Fragoulakis, V.; Roncato, R.; Fratte, C. D.; Ecca, F.; Bartsakoulia, M.; Innocenti, F.; Toffoli, G.; Cecchin, E.; Patrinos, G. P.; Mitropoulou, C. |